These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 20486830)

  • 21. Treatment of aggression with risperidone in children and adolescents with bipolar disorder: a case series.
    Saxena K; Chang K; Steiner H
    Bipolar Disord; 2006 Aug; 8(4):405-10. PubMed ID: 16879141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The first long-acting atypical antipsychotic: new milestone in the treatment of schizophrenia].
    Faludi G
    Neuropsychopharmacol Hung; 2005 Mar; 7(1):22-7. PubMed ID: 16167464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of neuropsychological effects of adjunctive risperidone or quetiapine in euthymic patients with bipolar I disorder.
    Kozicky JM; Torres IJ; Bond DJ; Lam RW; Yatham LN
    Int Clin Psychopharmacol; 2012 Mar; 27(2):91-9. PubMed ID: 22124206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative clinical responses to risperidone and divalproex in patients with pediatric bipolar disorder.
    MacMillan CM; Withney JE; Korndörfer SR; Tilley CA; Mrakotsky C; Gonzalez-Heydrich JM
    J Psychiatr Pract; 2008 May; 14(3):160-9. PubMed ID: 18520785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of long-acting risperidone in psychiatric disorders: focus on efficacy, safety and cost-effectiveness.
    Keith S
    Expert Rev Neurother; 2009 Jan; 9(1):9-31. PubMed ID: 19102665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Open-label prospective trial of risperidone in combination with lithium or divalproex sodium in pediatric mania.
    Pavuluri MN; Henry DB; Carbray JA; Sampson G; Naylor MW; Janicak PG
    J Affect Disord; 2004 Oct; 82 Suppl 1():S103-11. PubMed ID: 15571784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute and continuation risperidone monotherapy in mania.
    Vieta E; Brugué E; Goikolea JM; Sánchez-Moreno J; Reinares M; Comes M; Colom F; Martínez-Arán A; Benabarre A; Torrent C
    Hum Psychopharmacol; 2004 Jan; 19(1):41-5. PubMed ID: 14716711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antidepressants and antipsychotics in the long-term treatment of bipolar disorder.
    Kusumakar V
    J Clin Psychiatry; 2002; 63 Suppl 10():23-8. PubMed ID: 12392350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atypical antipsychotic augmentation of mood stabilizer therapy in bipolar disorder.
    Bowden CL
    J Clin Psychiatry; 2005; 66 Suppl 3():12-9. PubMed ID: 15762830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-Acting Injectable Second-Generation/Atypical Antipsychotics for the Management of Bipolar Disorder: A Systematic Review.
    Keramatian K; Chakrabarty T; Yatham LN
    CNS Drugs; 2019 May; 33(5):431-456. PubMed ID: 30963507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.
    Sheehan DV; McElroy SL; Harnett-Sheehan K; Keck PE; Janavs J; Rogers J; Gonzalez R; Shivakumar G; Suppes T
    J Affect Disord; 2009 Jun; 115(3):376-85. PubMed ID: 19042026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risperidone long-acting injection: in bipolar I disorder.
    Deeks ED
    Drugs; 2010 May; 70(8):1001-12. PubMed ID: 20481656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjunctive antipsychotic treatment of adolescents with bipolar psychosis.
    Kafantaris V; Coletti DJ; Dicker R; Padula G; Kane JM
    J Am Acad Child Adolesc Psychiatry; 2001 Dec; 40(12):1448-56. PubMed ID: 11765291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risperidone safety and efficacy in the treatment of bipolar and schizoaffective disorders: results from a 6-month, multicenter, open study.
    Vieta E; Goikolea JM; Corbella B; Benabarre A; Reinares M; Martínez G; Fernández A; Colom F; Martínez-Arán A; Torrent C;
    J Clin Psychiatry; 2001 Oct; 62(10):818-25. PubMed ID: 11816872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled study.
    Haas M; Delbello MP; Pandina G; Kushner S; Van Hove I; Augustyns I; Quiroz J; Kusumakar V
    Bipolar Disord; 2009 Nov; 11(7):687-700. PubMed ID: 19839994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical review of a long-acting, injectable formulation of risperidone.
    Knox ED; Stimmel GL
    Clin Ther; 2004 Dec; 26(12):1994-2002. PubMed ID: 15823763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risperidone treatment for juvenile bipolar disorder: a retrospective chart review.
    Frazier JA; Meyer MC; Biederman J; Wozniak J; Wilens TE; Spencer TJ; Kim GS; Shapiro S
    J Am Acad Child Adolesc Psychiatry; 1999 Aug; 38(8):960-5. PubMed ID: 10434487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atypical presentation of tardive dyskinesia associated with risperidone long-acting injection as maintenance treatment in bipolar affective disorder: a case report.
    Chung AK
    Curr Drug Saf; 2012 Feb; 7(1):21-3. PubMed ID: 22663952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of risperidone on plasma catecholamine metabolites and brain-derived neurotrophic factor in patients with bipolar disorders.
    Yoshimura R; Nakano Y; Hori H; Ikenouchi A; Ueda N; Nakamura J
    Hum Psychopharmacol; 2006 Oct; 21(7):433-8. PubMed ID: 17029305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.